These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9867529)

  • 21. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetic analysis of 1053 Danish individuals with clinical signs of familial hypercholesterolemia.
    Brusgaard K; Jordan P; Hansen H; Hansen AB; Hørder M
    Clin Genet; 2006 Mar; 69(3):277-83. PubMed ID: 16542394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW; Kastelein JJ; Defesche JC
    Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial defective apolipoprotein B-100: a cause of hypercholesterolemia and early coronary heart disease.
    Nassar BA
    CMAJ; 1993 Feb; 148(4):579-80. PubMed ID: 8431820
    [No Abstract]   [Full Text] [Related]  

  • 25. Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations.
    Callis M; Jansen S; Thiart R; de Villiers JN; Raal FJ; Kotze MJ
    Mol Cell Probes; 1998 Jun; 12(3):149-52. PubMed ID: 9664576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening for the new variant of defective receptor-binding apolipoprotein B-100].
    Li Y; Feng J; Li W
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(23):1434-5. PubMed ID: 11930615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of the R3531C mutation in the apoB gene in Czech hypercholesterolaemic patients.
    Vrablík M; Ceska R; Horínek A; Wichterle D
    Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):212-4. PubMed ID: 11590998
    [No Abstract]   [Full Text] [Related]  

  • 28. [MED-PED: make early diagnosis--prevent early death].
    Kostner GM
    Wien Med Wochenschr; 1994; 144(12-13):317-9. PubMed ID: 8650936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic causes of familial hypercholesterolaemia in a Malaysian population.
    Khoo KL; Van Acker P; Tan H; Deslypere JP
    Med J Malaysia; 2000 Dec; 55(4):409-18. PubMed ID: 11221151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid testing for three mutations causing familial defective apolipoprotein B100 in 562 patients with familial hypercholesterolaemia.
    Talmud PJ; Tamplin OJ; Heath K; Gaffney D; Day IN; Humphries SE
    Atherosclerosis; 1996 Aug; 125(1):135-7. PubMed ID: 8831935
    [No Abstract]   [Full Text] [Related]  

  • 31. Absence of familial defective apolipoprotein B-100 in Israeli patients with dominantly inherited hypercholesterolemia and in offspring with parental history of myocardial infarction.
    Friedlander Y; Dann EJ; Leitersdorf E
    Hum Genet; 1993 Apr; 91(3):299-300. PubMed ID: 8478017
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypercholesterolaemia presenting in a patient with familial defective apolipoprotein B-100 and hypothyroidism.
    Wenham PR; Giles PD; Ashby JP
    Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():221-5. PubMed ID: 7785956
    [No Abstract]   [Full Text] [Related]  

  • 33. Familial defective apolipoprotein B-100: a mutation emerged in the mesolithic ancestors of Celtic peoples?
    Miserez AR; Muller PY
    Atherosclerosis; 2000 Feb; 148(2):433-6. PubMed ID: 10657582
    [No Abstract]   [Full Text] [Related]  

  • 34. Approach to identification of a point mutation in apo B100 gene by means of a PCR-mediated site-directed mutagenesis.
    Schwartz EI; Shevtsov SP; Kuchinski AP; Kovalev YuP ; Plutalov OV; Berlin YuA
    Nucleic Acids Res; 1991 Jul; 19(13):3752. PubMed ID: 1852619
    [No Abstract]   [Full Text] [Related]  

  • 35. Homozygous familial hypercholesterolemia due to APOB genetic variant with unusual clinical course.
    Chlebus K; Żarczyńska-Buchowiecka M; Pajkowski M; Chmara M; Tromp TR; Gruchała M
    Kardiol Pol; 2021; 79(9):1030-1031. PubMed ID: 34125946
    [No Abstract]   [Full Text] [Related]  

  • 36. A novel splice-site mutation in intron 7 causes more severe hypercholesterolemia than a combined FH-FDB defect.
    deCampo A; Schallmoser K; Schmidt H; Toplak H; Kostner GM
    Atherosclerosis; 2001 Aug; 157(2):524-5. PubMed ID: 11472756
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic investigation of patients with hypercholesterolemia type IIa.
    Szalai C; Császár A; Czinner A; Palicz T; Halmos B; Romics L
    Clin Genet; 1999 Jan; 55(1):67-8. PubMed ID: 10066037
    [No Abstract]   [Full Text] [Related]  

  • 38. Candidate gene approach to type IIa hypercholesterolaemia.
    Benlian P; Bonaiti C; Douste-Blazy P; Junien C
    Lancet; 1989 May; 1(8648):1201-2. PubMed ID: 2566760
    [No Abstract]   [Full Text] [Related]  

  • 39. Familial defective apolipoprotein B-100: a tale of twin mutations.
    Andersen LH; Andersen RL; Miserez AR
    J Clin Lipidol; 2016; 10(4):1050-1051. PubMed ID: 27578140
    [No Abstract]   [Full Text] [Related]  

  • 40. Genotype/phenotype correlations in familial hypercholesterolaemia.
    Nicholls P; Young IS; Graham CA
    Curr Opin Lipidol; 1998 Aug; 9(4):313-7. PubMed ID: 9739486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.